Pregnancy of Unknown Location (PUL)
0
Pipeline Programs
2
Companies
2
Clinical Trials
1 recruiting
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket
Competitive Landscape
2 companies ranked by most advanced pipeline stage
Colorado TherapeuticsCO - Louisville
1 programat-home quantitative urine b-hCG testN/A1 trial
Active Trials
Trial Timeline
Clinical trial activity over time
2024
2025
2026
2027
2028
LaborieROM-Plus bedside test
Colorado Therapeuticsat-home quantitative urine b-hCG test
Clinical Trials (2)
Total enrollment: 157 patients across 2 trials
Expediting Pregnancy of Unknown Location Risk Stratification Using the ROM-Plus Point of Care Test
Start: Apr 2026Est. completion: Oct 2028122 patients
N/ANot Yet Recruiting
MIRA CONNECT Study
Start: Jun 2024Est. completion: Sep 202735 patients
N/ARecruiting
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
1 actively recruiting trials targeting 157 patients
2 companies competing in this space
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.